Cresanto Global Share Price Today | Stock Price & Cresanto Global Share Screener
As of September 21, 2026, the live Cresanto Global share price (BSE: CRESANTO) is ₹5.37, unchanged from the previous close, with shares trading between ₹5.37 and ₹5.37 in today's trading session, and a 52-week range of ₹3.83–₹5.37. Check CRESANTO price range for the annual price range and momentum. Use the Cresanto Global stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Cresanto Global opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Cresanto Global Share Price Chart
Track the current stock price of Cresanto Global with an interactive chart. Analyse CRESANTO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Cresanto Global stock quote in one place.
The quote of ₹5.37 sits between the 52-week low of ₹3.83 and the 52-week high of ₹5.37.
Cresanto Global Company Profile - Fundamental Screener
Screen Cresanto Global company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CRESANTO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE741C01017.
Company Details
Classification
Identifiers and Leadership
Cresanto Global Balance Sheet Screener
Screen CRESANTO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹0.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | -3 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | -7 | -7 | -7 | -6 | -6 | -6 | -6 | -6 | -6 | -6 |
Cresanto Global Income Statement Screener - Profit & Revenue Analysis
Screen Cresanto Global income statement and profit fundamentals. Analyze CRESANTO quarterly results. Cresanto Global reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹1 and net profit was ₹0, equal to earnings per unit of ₹-0.30, at an operating margin of -5%.
In that period expenses were ₹1, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹1 and net profit of ₹0.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||||||
| Revenue | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Costs and Margins | ||||||||||||
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -5.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | ||||||||||||
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | -0.30 | -0.42 | -0.24 | -0.40 | -0.19 | -0.16 | -0.13 | -0.13 | -0.13 | -0.12 | -0.09 | -0.04 |
Cresanto Global Cash Flow Screener - Liquidity Fundamentals
Screen CRESANTO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities used ₹1.
Over the same period, investing activities provided ₹1 and financing activities provided ₹0.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -1 | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cresanto Global Shareholding Pattern Screener
See Cresanto Global shareholding pattern with promoter, FII, and DII holdings. Check Cresanto Global promoter holding and ownership changes for CRESANTO on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Mar, promoters held 32.27%, foreign institutions 0.00%, domestic institutions 0.96% and the public 43.93%, spread across 1,490 shareholders.
The shareholder count was 1,490 in 2025-Mar, compared with 1,490 in 2025-Jun.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 32.27% | 32.27% | 32.27% | 32.27% | 28.36% | 28.36% | 28.36% | 28.36% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% | 0.96% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.93% | 43.93% | 44.15% | 44.15% | 47.80% | 47.90% | 47.90% | 47.86% |
| Other Holding | 22.83% | 22.83% | 22.62% | 22.62% | 22.88% | 22.78% | 22.78% | 22.82% |
| Shareholder Count | 1,490 | 1,490 | 1,482 | 1,482 | 1,504 | 1,503 | 1,497 | 1,494 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Cresanto Global. Cresanto Global dividend yield can be compared with peers and other stocks in the market.
Cresanto Global Stock Index Membership - Nifty & Sensex
See which indices include Cresanto Global stock. Check CRESANTO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Cresanto Global Market Events Screener - Corporate Actions
Get Cresanto Global corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Cresanto Global stock events that may affect CRESANTO share price, along with derivatives, futures and options activity and sector gainers.
10 corporate actions are listed, the most recent entry being Annual General Meeting dated .
It is followed by Annual General Meeting dated and Quarterly Result Announcement dated February 4, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.00% | ||
| Annual General Meeting | NA | 4.80% | ||
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | 0.00% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 0.00% |
| 2025-04-21 | 2025-04-21 | Extraordinary General Meeting | NA | 0.00% |
| 2025-03-25 | 2025-03-25 | Change Of Name | NA | 0.00% |
| 2025-01-27 | 2025-01-27 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | 0.00% |
Cresanto Global Competitors Screener - Peer Stocks Comparison
Screen CRESANTO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,899 | 38.94 | 54,729 | 9.71% | 10,980 | 49.38 |
| Divis Laboratories | 159,640 | 65.35 | 9,712 | 18.67% | 2,191 | 40.11 |
| Torrent Pharmaceuticals | 142,618 | 63.57 | 11,539 | 6.99% | 1,911 | 45.74 |
| Lupin | 104,913 | 22.73 | 22,910 | 13.74% | 3,306 | 52.63 |
| Dr Reddys Laboratories | 104,604 | 19.63 | 33,741 | 16.73% | 5,725 | 43.17 |
| Cipla | 98,694 | 22.38 | 28,410 | 7.12% | 5,291 | 26.47 |
| Zydus Life Science | 86,597 | 17.83 | 23,511 | 18.55% | 4,615 | 37.77 |
| Mankind Pharma | 79,564 | 45.78 | 12,744 | 20.90% | 2,007 | 32.45 |
| Aurobindo Pharma | 74,267 | 21.52 | 32,346 | 9.43% | 3,484 | 57.83 |
| Alkem Laboratories | 61,510 | 25.95 | 13,458 | 3.70% | 2,216 | 33.49 |
Cresanto Global Company Announcements - News & Reports Screener
Screen CRESANTO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated February 23, 2026.
The next most recent announcements are dated February 6, 2026 and February 5, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-02-23 | Board Meeting Outcome for Meeting Held On 23Rd February 2026 | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-02-04 | Results For The December Quarter 2025 | - |
| 2026-02-04 | Board Meeting Outcome for Meeting Held On 04Th February 2026 | - |
| 2026-01-31 | Board Meeting Intimation for Approval For Un-Audited Financials For The December 2025 Quarter. | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-27 | Closure of Trading Window | - |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-05 | Un-Audited Results For Q2 Ended 30Th September 2025 | - |
| 2025-11-05 | Board Meeting Outcome for Meeting Schedule On 05Th November 2025 | - |
| 2025-10-29 | Board Meeting Intimation for Meeting Schedule On 05Th November 2025 | - |
| 2025-10-28 | Intimation Under Reg. 30 For SEBI (LODR) Regulations 2015 For Filing Of Petition U/S. 66 Of The Companies Act 2013 | - |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-27 | Closure of Trading Window | - |
| 2025-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-09-03 | Reg. 34 (1) Annual Report. | - |
| 2025-09-03 | Fixes Book Closure For The 33Rd Annual General Meeting | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹5.37, within a 52-week range of ₹3.83 to ₹5.37. The P/E ratio is -14.77 and the P/B ratio is -0.70, with earnings per unit of ₹-0.42. Market capitalisation stands at ₹1.90 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 22, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.